These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2975263)

  • 1. Regulation of pathways of glucose metabolism in the kidney. The activity of the pentose phosphate pathway, glycolytic route and the regulation of phosphofructokinase in the kidney of lean and genetically obese (ob/ob) mice; comparison with effects of diabetes.
    Sochor M; Kunjara S; McLean P
    Horm Metab Res; 1988 Nov; 20(11):676-81. PubMed ID: 2975263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus.
    Karvonen I; Stengård JH; Huupponen R; Stenbäck FG; Sotaniemi EA
    Diabetes Res; 1989 Feb; 10(2):85-92. PubMed ID: 2501061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme activities of hepatic glucose utilization in the fed and fasting genetically obese mouse at 4-5 months of age.
    Hron WT; Sobocinski KA; Menahan LA
    Horm Metab Res; 1984 Dec; 16 Suppl 1():32-6. PubMed ID: 6241916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate metabolism in human renal clear cell carcinomas.
    Steinberg P; Störkel S; Oesch F; Thoenes W
    Lab Invest; 1992 Oct; 67(4):506-11. PubMed ID: 1434530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
    Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V
    Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enzymic spectrum of preneoplastic and neoplastic changes induced by 1,2-dimethylhydrazine in mouse kidneys].
    Ahn IS; Cheteris GIu; Turusov VS; Bannash P
    Arkh Patol; 1995; 57(6):52-7. PubMed ID: 8742189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic drug metabolism and the activities of NADPH generating enzymes and glucose-6-phosphatase in phenobarbital treated genetically obese (ob/ob) mice.
    Stengard JH; Saarni HU; Karvonen RI; Lahtela JT; Kärki NT; Stenbäck F; Sotaniemi EA
    Biomed Pharmacother; 1987; 41(7):389-96. PubMed ID: 2833324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanadate treatment increases the activity of glycolytic enzymes and raises fructose 2,6-bisphosphate concentration in hearts from diabetic rats.
    Sochor M; Kunjara S; Ali M; McLean P
    Biochem Int; 1992 Nov; 28(3):525-31. PubMed ID: 1482392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ponalrestat on sorbitol levels in the lens of obese and diabetic mice.
    Vicario PP; Slater EE; Saperstein R
    Biochem Int; 1989 Sep; 19(3):553-61. PubMed ID: 2510726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenalectomy in genetically obese ob/ob and db/db mice increases the proton conductance pathway.
    Shargill NS; Lupien JR; Bray GA
    Horm Metab Res; 1989 Sep; 21(9):463-7. PubMed ID: 2583669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of glucose metabolism in livers and kidneys of NOD mice.
    Sochor M; Kunjara S; Baquer NZ; McLean P
    Diabetes; 1991 Nov; 40(11):1467-71. PubMed ID: 1834502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte glyoxalase activity in genetically obese (ob/ob) and streptozotocin diabetic mice.
    Atkins TW; Thornally PJ
    Diabetes Res; 1989 Jul; 11(3):125-9. PubMed ID: 2627763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in pathways of pentose phosphate formation in relation to phosphoribosyl pyrophosphate synthesis in the developing rat kidney. Effects of glucose concentration and electron acceptors.
    Sochor M; Kunjara S; Greenbaum AL; McLean P
    J Dev Physiol; 1989 Sep; 12(3):135-43. PubMed ID: 2483165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin deficiency per se dictates body composition and insulin action in ob/ob mice.
    van den Hoek AM; Teusink B; Voshol PJ; Havekes LM; Romijn JA; Pijl H
    J Neuroendocrinol; 2008 Jan; 20(1):120-7. PubMed ID: 18081560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mononuclear leukocytes from obese patients with type II diabetes have reduced activity of hexokinase, 6-phosphofructokinase and glucose-6-phosphate dehydrogenase.
    Muggeo M; Moghetti P; Querena M; Cacciatori V; Zoppini G; Zenere M; Tosi F; Travia D; Bonora E
    Horm Metab Res; 1993 Mar; 25(3):160-4. PubMed ID: 8477954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age on hepatocyte and soleus muscle insulin receptor binding in lean and genetically obese diabetic (ob/ob) mice.
    Lord JM; Atkins TW
    Diabetes Res; 1985 Sep; 2(5):259-65. PubMed ID: 3905189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihyperglycaemic effect of saccharin in diabetic ob/ob mice.
    Bailey CJ; Day C; Knapper JM; Turner SL; Flatt PR
    Br J Pharmacol; 1997 Jan; 120(1):74-8. PubMed ID: 9117102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.
    Halseth AE; Ensor NJ; White TA; Ross SA; Gulve EA
    Biochem Biophys Res Commun; 2002 Jun; 294(4):798-805. PubMed ID: 12061777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice.
    Shimomura Y; Bray GA; Lee M
    Horm Metab Res; 1987 Jul; 19(7):295-9. PubMed ID: 2957297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.